Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Pfizer in court over Chinese stealing trade secrets

<< Previous

Bullboard Posts

Next >>

Comment by itntdfon Feb 08, 2023 2:40pm

142 Views

Post# 35275172

RE:RE:RE:RE:RE:RE:RE:Pfizer in court over Chinese stealing trade secrets

for all of your 'warnings" about how hedge funds and mm's want to "steal your shares", that type of claptrap answer ("spidey sense" i.e. noteable nonsense) is nothing more than what you have railed against on this board.

get real.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand